Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)
伊布替尼联合奥法妥木单抗巩固治疗既往未接受治疗的慢性淋巴细胞白血病 (CLL) 患者：西班牙 CLL 组 (GELLC) 的 GELLC-7 试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102642
Abrisqueta, Pau; González-Barca, Eva; Ferrà, Christelle; Ríos-Herranz, Eduardo; Fernández de la Mata, Margarita; Delgado, Julio; Andreu, Rafael; Hernández-Rivas, José Ángel; Terol, María José; Navarro, Almudena; Vidriales, M Belén; Baltasar, Patricia; De la Serna, Javier; Ramírez, Ángel; Ballester, Carmen; Moreno, Carol; García-Marco, José Antonio; Córdoba, Raúl; Yáñez, Lucrecia; Casado, Luís Felipe; González, Marcos; Bosch, Francesc
